Open AccessIntracameral Recombinant Tissue Plasminogen Activator (rtPA) as the Primary Treatment for Secondary Pupillary Block
Author(s) -
Safinaz Mohd Khialdin
Publication year - 2022
Publication title -
medicine and health
Language(s) - English
Resource type - Journals
eISSN - 2289-5728
pISSN - 1823-2140
DOI - 10.17576/mh.2022.1701.24
Subject(s) - medicine , vitrectomy , miosis , ophthalmology , pupil , tissue plasminogen activator , intraocular lens , mydriasis , iridectomy , fibrinolysis , surgery , anesthesia , glaucoma , visual acuity , neuroscience , biology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom